Utility of stress echocardiography in selecting the optimal mitral valve procedure in patients with severe ischemic mitral regurgitation undergoing coronary artery bypass grafting
Authors:
- Janusz KochanowskiJKJanusz Kochanowski
- Radosław PiątkowskiRPRadosław Piątkowski
- Marcin GrabowskiMGMarcin Grabowski
- Marek RoikMRMarek Roik
- Piotr ScisłoPSPiotr Scisło
- Grzegorz OpolskiGOGrzegorz Opolski
Open Access
- 11 April 2012
- journal article
- research article
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 122 (5) , 217-225
Abstract
INTRODUCTION Severe functional ischemic mitral regurgitation (FIMR) considerably worsens the prognosis of patients after myocardial infarction. The complex pathomechanism of FIMR and its dynamic nature make it difficult to develop effective therapeutic methods. OBJECTIVES The aim of the study was to prospectively assess a diagnostic strategy based on stress echocardiography in referring patients with severe FIMR for appropriate surgical procedure: coronary artery bypass grafting alone (CABGa) or CABG with mitral annuloplasty (CABGma) or replacement (CABGmr). PATIENTS AND METHODS A prospective analysis included 42 patients (23 women, 19 men) aged 67 +/- 12 years with severe FIMR after myocardial infarction, scheduled for CABG. In each patient, mitral valve morphology, left ventricular function, FIMR degree as assessed by the effective regurgitation orifice area (severe >= 20 mm(2)), myocardial viability, and mitral deformation indexes were assessed prior to surgery. Based on clinical assessment and rest and stress echocardiography parameters, patients were referred for CABGa (group 1; n = 6), CABGma (group 2; n = 27), or CABGmr (group 3; n = 9). RESULTS In all study groups, no differences in clinical and echocardiographic results were observed during a 12-month follow-up. A significant improvement was reported in the majority of patients regardless of the surgical procedure. Early (30-day) mortality in the whole study population was 11.9% (n = 5). Survival at 12 months was 100%, 81.5%, and 77.8% for groups 1, 2, and 3, respectively (P = 0.3). In all study groups, a statistically significant FIMR reduction was observed in a 12-month follow-up: small, moderate, and severe FIMR was observed in 29 (83%), 5 (14%), and 1 (3%) surviving patient, respectively. Reverse left ventricular remodeling was observed in 83% of the patients in group 1, 63.7% in group 2, and 100% in group 3 (statistically nonsignificant difference). CONCLUSIONS The presented diagnostic strategy, based on stress echocardiography, may facilitate the process of choosing a suitable cardiac surgical procedure for patients with severe FIMR.Keywords
This publication has 14 references indexed in Scilit:
- How to manage ischaemic mitral regurgitationHeart, 2008
- American Society of Echocardiography Recommendations for Performance, Interpretation, and Application of Stress EchocardiographyJournal of the American Society of Echocardiography, 2007
- Impact of Mitral Valve Annuloplasty Combined With Revascularization in Patients With Functional Ischemic Mitral RegurgitationJACC, 2007
- Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of CardiologyEuropean Heart Journal, 2006
- Ischemic Mitral Regurgitation: Revascularization Alone Versus Revascularization and Mitral Valve RepairThe Annals of Thoracic Surgery, 2005
- Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation☆European Journal of Cardio-Thoracic Surgery, 2005
- Long-term outcome of patients with heart failure and dynamic functional mitral regurgitationEuropean Heart Journal, 2005
- Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarctionJACC, 2005
- Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitationThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Repair of ischemic mitral regurgitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: A propensity analysisThe Annals of Thoracic Surgery, 2004